uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells

Alapati,Kiranmai; Gopinath,Sreelatha; Malla,Rama  Rao; Dasari,Venkata  Ramesh; Rao,Jasti  S.

doi:10.3892/ijo.2012.1496

uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells

Authors:
- Kiranmai Alapati
- Sreelatha Gopinath
- Rama Rao Malla
- Venkata Ramesh Dasari
- Jasti S. Rao
View Affiliations

Affiliations: Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA
Published online on: May 24, 2012 https://doi.org/10.3892/ijo.2012.1496
Pages: 599-610

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite advances in radiotherapeutic and chemotherapeutic techniques and aggressive surgical resection, the prognosis of glioblastoma patients is dismal. Accumulation of evidence indicates that some cancer cells survive even the most aggressive treatments, and these surviving cells, which are resistant to therapy and are perhaps essential for the malignancy, may be cancer stem cells. The CD133 surface marker is commonly used to isolate these extremely resistant glioma-initiating cells (GICs). In the present study, GICs which tested positive for the CD133 marker (CD133+) were isolated from both the established U251 cell line and the 5310 xenograft glioma cell line to study the events related to the molecular pathogenesis of these cells. Simultaneous down-regulation of uPAR and cathepsin B by shRNA (pUC) treatment caused the disruption of radiation-induced complex formation of pPKC θ/δ, integrin β1 and PKC ζ, integrin β1 in glioma cells. Further, pUC treatment inhibited PKC/integrin signaling via FAK by causing disassociation of FAK and the cytoskeletal molecules vinculin and α-actinin. Also, we observed the inhibition of ERK phosphorylation. This inhibition was mediated by pUC and directed a negative feedback mechanism over the FAK signaling molecules, which led to an extensive reduction in the signal for cytoskeletal organization generating migratory arrest. Altogether, it can be hypothesized that knockdown of uPAR and cathepsin B using shRNA is an effective strategy for controlling highly invasive glioma cells and extremely resistant glioma-initiating cells.

View Figures

View References

1	Huang Z, Cheng L, Guryanova OA, Wu Q and Bao S: Cancer stem cells in glioblastoma - molecular signaling and therapeutic targeting. Protein Cell. 1:638–655. 2010. View Article : Google Scholar : PubMed/NCBI
2	Huang CY, Fong YC, Lee CY, et al: CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol. 77:794–803. 2009. View Article : Google Scholar : PubMed/NCBI
3	Mitra SK and Schlaepfer DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
4	Wolf K and Friedl P: Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol. 154(Suppl 1): 11–15. 2006. View Article : Google Scholar
5	Da Rocha AB, Mans DR, Regner A and Schwartsmann G: Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? Oncologist. 7:17–33. 2002.PubMed/NCBI
6	Rigot V, Lehmann M, Andre F, Daemi N, Marvaldi J and Luis J: Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J Cell Sci. 111:3119–3127. 1998.PubMed/NCBI
7	Larsson C: Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal. 18:276–284. 2006. View Article : Google Scholar : PubMed/NCBI
8	Chintala SK, Mohanam S, Go Y, et al: Altered in vitro spreading and cytoskeletal organization in human glioma cells by down-regulation of urokinase receptor. Mol Carcinog. 20:355–365. 1997. View Article : Google Scholar : PubMed/NCBI
9	Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 3:489–501. 2003. View Article : Google Scholar : PubMed/NCBI
10	Gopinath S, Malla RR, Gondi CS, et al: Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation. PLoS One. 5:e116682010. View Article : Google Scholar : PubMed/NCBI
11	Malla RR, Gopinath S, Gondi CS, et al: Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma. Cancer Gene Ther. 18:419–434. 2011. View Article : Google Scholar : PubMed/NCBI
12	Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004. View Article : Google Scholar : PubMed/NCBI
13	Gilbert CA and Ross AH: Glioma stem cells: cell culture, markers and targets for new combination therapies. Cancer Stem Cells Theories and Practice. Shostak S: InTech; pp. 79–104. 2011
14	Pollard SM, Yoshikawa K, Clarke ID, et al: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar : PubMed/NCBI
15	Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821–5828. 2003.PubMed/NCBI
16	Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
17	Gondi CS, Kandhukuri N, Kondraganti S, et al: RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther. 5:3197–3208. 2006. View Article : Google Scholar
18	Kim MJ, Kim RK, Yoon CH, et al: Importance of PKCdelta signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment. J Cell Sci. 124:3084–3094. 2011. View Article : Google Scholar : PubMed/NCBI
19	Donald CD, Cooper CR, Harris-Hooker S, Emmett N, Scanlon M and Cooke DB III: Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer. Cell Mol Biol (Noisy-le-grand). 47:1033–1038. 2001.PubMed/NCBI
20	Uhm JH, Gladson CL and Rao JS: The role of integrins in the malignant phenotype of gliomas. Front Biosci. 4:D188–D199. 1999. View Article : Google Scholar : PubMed/NCBI
21	Carriero MV, Del Vecchio S, Capozzoli M, et al: Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res. 59:5307–5314. 1999.PubMed/NCBI
22	Gunther W, Skaftnesmo KO, Arnold H and Terzis AJ: Molecular approaches to brain tumour invasion. Acta Neurochir (Wien). 145:1029–1036. 2003. View Article : Google Scholar : PubMed/NCBI
23	Bruce-Staskal PJ and Bouton AH: PKC-dependent activation of FAK and src induces tyrosine phosphorylation of Cas and formation of Cas-Crk complexes. Exp Cell Res. 264:296–306. 2001. View Article : Google Scholar : PubMed/NCBI
24	Chen CS, Alonso JL, Ostuni E, Whitesides GM and Ingber DE: Cell shape provides global control of focal adhesion assembly. Biochem Biophys Res Commun. 307:355–361. 2003. View Article : Google Scholar : PubMed/NCBI
25	Clark EA, King WG, Brugge JS, Symons M and Hynes RO: Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol. 142:573–586. 1998. View Article : Google Scholar : PubMed/NCBI
26	Parsons M, Keppler MD, Kline A, et al: Site-directed perturbation of protein kinase C-integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol. 22:5897–5911. 2002. View Article : Google Scholar : PubMed/NCBI
27	Lin CJ, Lin CY, Chen Y, Huang SH and Wang SM: Rottlerin inhibits migration of follicular thyroid carcinoma cells by PKCdelta-independent destabilization of the focal adhesion complex. J Cell Biochem. 110:428–437. 2010.